Search
forResearch 10 of 381
- Chemotherapy-Induced Alopecia by Docetaxel: Prevalence, Treatment and Prevention
- Abstract P5-21-05: ERALOP study: Post adjuvant FEC - docetaxel chemotherapy for early breast cancer: Hair regrowth in the real life
- Periungual lesions secondary to chemotherapy with docetaxel
- High incidence of severe hand–foot syndrome during capecitabine–docetaxel combination chemotherapy
- Comparison of pemetrexed and docetaxel as salvage chemotherapy for the treatment for nonsmall-cell lung cancer after the failure of epidermal growth factor receptor-tyrosine kinase inhibitors
- Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients
- Dermatological adverse events with taxane chemotherapy
- Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatment
- Permanent chemotherapy-induced alopecia: Case report and review of the literature
- Chemotherapy-Induced Alopecia in Breast Cancer Patients: Treatment-Specific Incidence and Risk of Persistent Hair Loss
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →